Global Companion Diagnostic Technologies Market Research Report 2024(Status and Outlook)

Global Companion Diagnostic Technologies Market Research Report 2024(Status and Outlook)



Report Overview:

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment.

The Global Companion Diagnostic Technologies Market Size was estimated at USD 3193.36 million in 2023 and is projected to reach USD 6070.42 million by 2029, exhibiting a CAGR of 11.30% during the forecast period.

This report provides a deep insight into the global Companion Diagnostic Technologies market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Diagnostic Technologies Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Diagnostic Technologies market in any manner.

Global Companion Diagnostic Technologies Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Dako (Agilent Technologies)

Qiagen

Roche

Abbott Laboratories

Thermo Fisher Scientific

bioMerieux

Myriad Genetics

Resonance Health Ltd.

Leica Microsystems

Danaher

Market Segmentation (by Type)

Immunohistochemistry

Molecular Diagnostics

Market Segmentation (by Application)

Oncology

Cardiovascular

Central Nervous System

Auto immune & Inflammation

Virology

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Companion Diagnostic Technologies Market

Overview of the regional outlook of the Companion Diagnostic Technologies Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostic Technologies Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Companion Diagnostic Technologies
1.2 Key Market Segments
1.2.1 Companion Diagnostic Technologies Segment by Type
1.2.2 Companion Diagnostic Technologies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Companion Diagnostic Technologies Market Overview
2.1 Global Market Overview
2.1.1 Global Companion Diagnostic Technologies Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Companion Diagnostic Technologies Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Companion Diagnostic Technologies Market Competitive Landscape
3.1 Global Companion Diagnostic Technologies Sales by Manufacturers (2019-2024)
3.2 Global Companion Diagnostic Technologies Revenue Market Share by Manufacturers (2019-2024)
3.3 Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Companion Diagnostic Technologies Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Companion Diagnostic Technologies Sales Sites, Area Served, Product Type
3.6 Companion Diagnostic Technologies Market Competitive Situation and Trends
3.6.1 Companion Diagnostic Technologies Market Concentration Rate
3.6.2 Global 5 and 10 Largest Companion Diagnostic Technologies Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Companion Diagnostic Technologies Industry Chain Analysis
4.1 Companion Diagnostic Technologies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Companion Diagnostic Technologies Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Companion Diagnostic Technologies Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostic Technologies Sales Market Share by Type (2019-2024)
6.3 Global Companion Diagnostic Technologies Market Size Market Share by Type (2019-2024)
6.4 Global Companion Diagnostic Technologies Price by Type (2019-2024)
7 Companion Diagnostic Technologies Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostic Technologies Market Sales by Application (2019-2024)
7.3 Global Companion Diagnostic Technologies Market Size (M USD) by Application (2019-2024)
7.4 Global Companion Diagnostic Technologies Sales Growth Rate by Application (2019-2024)
8 Companion Diagnostic Technologies Market Segmentation by Region
8.1 Global Companion Diagnostic Technologies Sales by Region
8.1.1 Global Companion Diagnostic Technologies Sales by Region
8.1.2 Global Companion Diagnostic Technologies Sales Market Share by Region
8.2 North America
8.2.1 North America Companion Diagnostic Technologies Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Companion Diagnostic Technologies Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Companion Diagnostic Technologies Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Companion Diagnostic Technologies Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Companion Diagnostic Technologies Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Dako (Agilent Technologies)
9.1.1 Dako (Agilent Technologies) Companion Diagnostic Technologies Basic Information
9.1.2 Dako (Agilent Technologies) Companion Diagnostic Technologies Product Overview
9.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Product Market Performance
9.1.4 Dako (Agilent Technologies) Business Overview
9.1.5 Dako (Agilent Technologies) Companion Diagnostic Technologies SWOT Analysis
9.1.6 Dako (Agilent Technologies) Recent Developments
9.2 Qiagen
9.2.1 Qiagen Companion Diagnostic Technologies Basic Information
9.2.2 Qiagen Companion Diagnostic Technologies Product Overview
9.2.3 Qiagen Companion Diagnostic Technologies Product Market Performance
9.2.4 Qiagen Business Overview
9.2.5 Qiagen Companion Diagnostic Technologies SWOT Analysis
9.2.6 Qiagen Recent Developments
9.3 Roche
9.3.1 Roche Companion Diagnostic Technologies Basic Information
9.3.2 Roche Companion Diagnostic Technologies Product Overview
9.3.3 Roche Companion Diagnostic Technologies Product Market Performance
9.3.4 Roche Companion Diagnostic Technologies SWOT Analysis
9.3.5 Roche Business Overview
9.3.6 Roche Recent Developments
9.4 Abbott Laboratories
9.4.1 Abbott Laboratories Companion Diagnostic Technologies Basic Information
9.4.2 Abbott Laboratories Companion Diagnostic Technologies Product Overview
9.4.3 Abbott Laboratories Companion Diagnostic Technologies Product Market Performance
9.4.4 Abbott Laboratories Business Overview
9.4.5 Abbott Laboratories Recent Developments
9.5 Thermo Fisher Scientific
9.5.1 Thermo Fisher Scientific Companion Diagnostic Technologies Basic Information
9.5.2 Thermo Fisher Scientific Companion Diagnostic Technologies Product Overview
9.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Product Market Performance
9.5.4 Thermo Fisher Scientific Business Overview
9.5.5 Thermo Fisher Scientific Recent Developments
9.6 bioMerieux
9.6.1 bioMerieux Companion Diagnostic Technologies Basic Information
9.6.2 bioMerieux Companion Diagnostic Technologies Product Overview
9.6.3 bioMerieux Companion Diagnostic Technologies Product Market Performance
9.6.4 bioMerieux Business Overview
9.6.5 bioMerieux Recent Developments
9.7 Myriad Genetics
9.7.1 Myriad Genetics Companion Diagnostic Technologies Basic Information
9.7.2 Myriad Genetics Companion Diagnostic Technologies Product Overview
9.7.3 Myriad Genetics Companion Diagnostic Technologies Product Market Performance
9.7.4 Myriad Genetics Business Overview
9.7.5 Myriad Genetics Recent Developments
9.8 Resonance Health Ltd.
9.8.1 Resonance Health Ltd. Companion Diagnostic Technologies Basic Information
9.8.2 Resonance Health Ltd. Companion Diagnostic Technologies Product Overview
9.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Product Market Performance
9.8.4 Resonance Health Ltd. Business Overview
9.8.5 Resonance Health Ltd. Recent Developments
9.9 Leica Microsystems
9.9.1 Leica Microsystems Companion Diagnostic Technologies Basic Information
9.9.2 Leica Microsystems Companion Diagnostic Technologies Product Overview
9.9.3 Leica Microsystems Companion Diagnostic Technologies Product Market Performance
9.9.4 Leica Microsystems Business Overview
9.9.5 Leica Microsystems Recent Developments
9.10 Danaher
9.10.1 Danaher Companion Diagnostic Technologies Basic Information
9.10.2 Danaher Companion Diagnostic Technologies Product Overview
9.10.3 Danaher Companion Diagnostic Technologies Product Market Performance
9.10.4 Danaher Business Overview
9.10.5 Danaher Recent Developments
10 Companion Diagnostic Technologies Market Forecast by Region
10.1 Global Companion Diagnostic Technologies Market Size Forecast
10.2 Global Companion Diagnostic Technologies Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Companion Diagnostic Technologies Market Size Forecast by Country
10.2.3 Asia Pacific Companion Diagnostic Technologies Market Size Forecast by Region
10.2.4 South America Companion Diagnostic Technologies Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Companion Diagnostic Technologies by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Companion Diagnostic Technologies Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Companion Diagnostic Technologies by Type (2025-2030)
11.1.2 Global Companion Diagnostic Technologies Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Companion Diagnostic Technologies by Type (2025-2030)
11.2 Global Companion Diagnostic Technologies Market Forecast by Application (2025-2030)
11.2.1 Global Companion Diagnostic Technologies Sales (K Units) Forecast by Application
11.2.2 Global Companion Diagnostic Technologies Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings